Biofluidic material-based carriers: Potential systems for crossing cellular barriers

J Control Release. 2021 Jan 10:329:858-870. doi: 10.1016/j.jconrel.2020.10.017. Epub 2020 Oct 11.

Abstract

Biofluids act as a repository for disease biomarkers and are excellent diagnostic tools applied in establishing a disease profile based on clinical testing, evaluation and monitoring the progression of patients suffering from various conditions. Furthermore, biofluids and their derived components such proteins, pigments, enzymes, hormones and cells carry a potential in the development of therapeutic drug delivery systems or as cargo materials for targeting the drug to the site of action. The presence of biofluids with respect to their specific location reveals the information of disease progression and mechanism, delivery aspects such as routes of administration as well as pharmacological factors such as binding affinity, rate of kinetics, efficacy, bioavailability and patient compliance. This review focuses on the properties and functional benefits of some biofluids, namely blood, saliva, bile, urine, amniotic fluid, synovial fluid and cerebrospinal fluid. It also covers the therapeutic and targeting action of fluid-derived substances in various micro- or nano-systems like nanohybrids, nanoparticles, self-assembled micelles, microparticles, cell-based systems, etc. The formulation of such biologically-oriented systems demonstrate the advantages of natural origin, biocompatibility and biodegradability and offer new techniques for overcoming the challenges experienced in conventional therapies.

Keywords: Cargo; Cell-based; Enzyme; Fluid flow; Nanomedicine.

Publication types

  • Review

MeSH terms

  • Drug Carriers
  • Drug Delivery Systems
  • Humans
  • Micelles
  • Nanomedicine*
  • Nanoparticles*

Substances

  • Drug Carriers
  • Micelles